Dual blockade of TIM-3 and PD-1 in combination with stereotactic radiosurgery (SRS) was associated with a 100% overall survival (OS) rate (p < 0.05) and rejection of tumor rechallenge [20]. Here, PDCD1 is linked to neoplasm.